Wockhardt Limited (WOCKPHARMA.NS)
INR 1310.1
(1.03%)
INR 1310.1
(1.03%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 18.27 Billion INR | -12.75% |
| 2022 | 20.94 Billion INR | 14.55% |
| 2021 | 18.28 Billion INR | -25.1% |
| 2020 | 24.4 Billion INR | -27.42% |
| 2019 | 33.62 Billion INR | 12.95% |
| 2018 | 29.77 Billion INR | 4.44% |
| 2017 | 28.5 Billion INR | -10.46% |
| 2016 | 31.83 Billion INR | 82.22% |
| 2015 | 17.47 Billion INR | 104.78% |
| 2014 | 8.53 Billion INR | 5.85% |
| 2013 | 8.06 Billion INR | -21.07% |
| 2012 | 10.21 Billion INR | -54.95% |
| 2011 | 22.67 Billion INR | -32.72% |
| 2010 | 33.69 Billion INR | -8.3% |
| 2009 | 36.74 Billion INR | 2.31% |
| 2008 | 35.91 Billion INR | 41.98% |
| 2007 | 25.29 Billion INR | 153.71% |
| 2006 | 9.97 Billion INR | 417.76% |
| 2005 | 1.92 Billion INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | 1.15 Billion INR | -94.82% |
| 2023 Q4 | 18.27 Billion INR | 1488.7% |
| 2023 FY | 18.27 Billion INR | -12.75% |
| 2023 Q1 | 1.16 Billion INR | -94.46% |
| 2023 Q2 | 22.2 Billion INR | 1813.79% |
| 2022 Q3 | 2.34 Billion INR | -88.21% |
| 2022 Q1 | 3.82 Billion INR | -79.1% |
| 2022 Q2 | 19.84 Billion INR | 419.37% |
| 2022 FY | 20.94 Billion INR | 14.55% |
| 2022 Q4 | 20.94 Billion INR | 794.87% |
| 2021 FY | 18.28 Billion INR | -25.1% |
| 2021 Q2 | 25.1 Billion INR | 845.68% |
| 2021 Q4 | 18.28 Billion INR | 455.03% |
| 2021 Q3 | 3.29 Billion INR | -86.88% |
| 2021 Q1 | 2.65 Billion INR | -89.12% |
| 2020 Q1 | 2.28 Billion INR | -93.21% |
| 2020 FY | 24.4 Billion INR | -27.42% |
| 2020 Q2 | 13.46 Billion INR | 490.24% |
| 2020 Q4 | 24.4 Billion INR | 0.0% |
| 2019 FY | 33.62 Billion INR | 12.95% |
| 2019 Q4 | 33.62 Billion INR | 1246.84% |
| 2019 Q3 | 2.49 Billion INR | -89.59% |
| 2019 Q2 | 23.97 Billion INR | 503.3% |
| 2019 Q1 | 3.97 Billion INR | -86.65% |
| 2018 Q1 | 12.95 Billion INR | -54.55% |
| 2018 Q3 | 6.69 Billion INR | -65.69% |
| 2018 Q4 | 29.77 Billion INR | 344.73% |
| 2018 FY | 29.77 Billion INR | 4.44% |
| 2018 Q2 | 19.51 Billion INR | 50.63% |
| 2017 Q1 | 21.95 Billion INR | -31.05% |
| 2017 FY | 28.5 Billion INR | -10.46% |
| 2017 Q4 | 28.5 Billion INR | 79.59% |
| 2017 Q3 | 15.87 Billion INR | -48.59% |
| 2017 Q2 | 30.87 Billion INR | 40.64% |
| 2016 FY | 31.83 Billion INR | 82.22% |
| 2016 Q4 | 31.83 Billion INR | 36.85% |
| 2016 Q3 | 23.26 Billion INR | -4.93% |
| 2016 Q2 | 24.46 Billion INR | 65.55% |
| 2016 Q1 | 14.78 Billion INR | -15.4% |
| 2015 Q3 | 14.4 Billion INR | 115.08% |
| 2015 FY | 17.47 Billion INR | 104.78% |
| 2015 Q2 | 6.69 Billion INR | -57.43% |
| 2015 Q1 | 15.73 Billion INR | 84.39% |
| 2015 Q4 | 17.47 Billion INR | 21.3% |
| 2014 Q2 | 2.75 Billion INR | -83.8% |
| 2014 Q1 | 16.99 Billion INR | 110.88% |
| 2014 FY | 8.53 Billion INR | 5.85% |
| 2014 Q4 | 8.53 Billion INR | -29.62% |
| 2014 Q3 | 12.12 Billion INR | 340.34% |
| 2013 Q2 | 5.57 Billion INR | -49.1% |
| 2013 Q1 | 10.96 Billion INR | 7.32% |
| 2013 FY | 8.06 Billion INR | -21.07% |
| 2013 Q4 | 8.06 Billion INR | -44.03% |
| 2013 Q3 | 14.4 Billion INR | 158.15% |
| 2012 FY | 10.21 Billion INR | -54.95% |
| 2012 Q3 | 19.37 Billion INR | 200.0% |
| 2012 Q4 | 10.21 Billion INR | -47.3% |
| 2012 Q2 | -19.37 Billion INR | 0.0% |
| 2011 FY | 22.67 Billion INR | -32.72% |
| 2011 Q4 | 22.67 Billion INR | 0.0% |
| 2010 FY | 33.69 Billion INR | -8.3% |
| 2009 FY | 36.74 Billion INR | 2.31% |
| 2008 FY | 35.91 Billion INR | 41.98% |
| 2007 FY | 25.29 Billion INR | 153.71% |
| 2006 FY | 9.97 Billion INR | 417.76% |
| 2005 FY | 1.92 Billion INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Amrutanjan Health Care Limited | -248.79 Million INR | 7443.484% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 99145.864% |
| Caplin Point Laboratories Limited | -5.5 Billion INR | 431.717% |
| FDC Limited | -57.75 Million INR | 31735.268% |
| Gufic Biosciences Limited | 3.19 Billion INR | -471.953% |
| Hikal Limited | 7.96 Billion INR | -129.321% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 539.917% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 1758.949% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | -15120.053% |
| Medico Remedies Limited | 78.67 Million INR | -23121.526% |
| Nectar Lifesciences Limited | 6.15 Billion INR | -196.721% |
| Par Drugs and Chemicals Limited | -366.53 Million INR | 5084.463% |
| RPG Life Sciences Limited | -364.7 Million INR | 5109.597% |
| Sequent Scientific Limited | 4.17 Billion INR | -337.225% |
| Shilpa Medicare Limited | 9.06 Billion INR | -101.444% |
| Sigachi Industries Limited | 859.94 Million INR | -2024.545% |
| Themis Medicare Limited | 764.96 Million INR | -2288.354% |
| Unichem Laboratories Limited | 931.91 Million INR | -1860.477% |
| Venus Remedies Limited | -267.7 Million INR | 6924.804% |
| Wanbury Limited | 1.1 Billion INR | -1552.085% |
| ZIM Laboratories Limited | 983.6 Million INR | -1757.455% |
| Lupin Limited | 19.38 Billion INR | 5.751% |
| Innova Captab Limited | 2.33 Billion INR | -682.857% |
| Ind-Swift Limited | 9.5 Billion INR | -92.142% |
| Bajaj HealthCare Limited | 3.29 Billion INR | -453.812% |
| Aurobindo Pharma Limited | 3.69 Billion INR | -394.68% |
| Solara Active Pharma Sciences Limited | 10.03 Billion INR | -82.121% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 464.493% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | -1772.289% |
| Morepen Laboratories Limited | -231.17 Million INR | 8003.138% |
| Laurus Labs Limited | 24.35 Billion INR | 24.992% |
| Aarti Drugs Limited | 5.54 Billion INR | -229.284% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 742.708% |
| Alembic Limited | 66.9 Million INR | -27209.417% |
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | -372.594% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 526.345% |
| Vaishali Pharma Limited | 119.13 Million INR | -15235.544% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | -599.491% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 1414.455% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 32.513% |
| Eris Lifesciences Limited | 13.8 Billion INR | -32.33% |
| Windlas Biotech Limited | -273.04 Million INR | 6791.327% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 125.21% |
| Lincoln Pharmaceuticals Limited | -127.63 Million INR | 14413.919% |
| Orchid Pharma Limited | -1.31 Billion INR | 1490.575% |
| Albert David Limited | -278.36 Million INR | 6663.231% |
| Hester Biosciences Limited | 2.29 Billion INR | -697.559% |
| Sakar Healthcare Limited | 790.93 Million INR | -2209.918% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | -12502.086% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 878.109% |
| Divi's Laboratories Limited | -39.77 Billion INR | 145.939% |
| Mankind Pharma Limited | -1.74 Billion INR | 1144.985% |
| Neuland Laboratories Limited | -214.05 Million INR | 8635.07% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | -547.597% |
| Zydus Lifesciences Limited | 3.91 Billion INR | -367.025% |
| Bal Pharma Limited | 1.26 Billion INR | -1345.914% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | -41.485% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 1678.058% |
| Alkem Laboratories Limited | -1.6 Billion INR | 1235.206% |
| Valiant Laboratories Limited | 649.9 Million INR | -2711.193% |
| Ajanta Pharma Limited | -954.9 Million INR | 2013.289% |
| Bafna Pharmaceuticals Limited | 229.93 Million INR | -7845.793% |
| Aarey Drugs & Pharmaceuticals Limited | 297.57 Million INR | -6039.541% |
| Granules India Limited | 9.28 Billion INR | -96.731% |
| Medicamen Biotech Limited | 160.31 Million INR | -11296.242% |
| Ipca Laboratories Limited | 11.41 Billion INR | -60.05% |
| Brooks Laboratories Limited | 49.48 Million INR | -36820.279% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -39436.041% |
| Piramal Enterprises Limited | 491.39 Billion INR | 96.282% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 42.601% |
| NATCO Pharma Limited | -5.81 Billion INR | 414.079% |
| Suven Life Sciences Limited | -1.63 Billion INR | 1219.007% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -845.202% |
| Strides Pharma Science Limited | 23.25 Billion INR | 21.443% |
| Indoco Remedies Limited | 6.47 Billion INR | -182.106% |
| Alpa Laboratories Limited | 35.36 Million INR | -51564.169% |
| Lasa Supergenerics Limited | 205.79 Million INR | -8777.594% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 2039.902% |